A diet that includes aquatic plants and green tea and less red meat could lower the occurrence of NAFLD.

The experimental therapy improved liver inflammation, fibrosis and metabolic parameters in six months.

The diabetes medication, alone or in combination regimens, led to improvements in NASH and fibrosis.

A Mediterranean diet could help reduce the risk of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.

The link between COVID-19 and liver disease, along with research about NAFLD and NASH, topped the Hep treatment news this year.

Vitamin B-12 and folate not only lowered homocysteine levels in the blood but also improved liver inflammation in mice.

Researchers suggest that 67.3 million people are living with NAFLD in the United States and Canada.

Fatty liver disease is caused by excess fat in the liver. When fat accumulates, the liver becomes inflamed and damaged.

If passed, the law would boost liver disease research and create a national strategy to tackle non-alcoholic steatohepatitis.

Associations with sleep efficiency and daytime dysfunction varied based on sex.